Orasis Pharmaceuticals and Aspen Australia announced that Aspen has submitted a New Drug Application in Australia to the ...
Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking ...
As technology evolves, there is potential to quantify and automate presbyopia-correcting IOL selection through measures that ...
NEW YORK--(BUSINESS WIRE)-- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced ...
When it comes to refractive surgery, not all patients are created equal. A 28-year-old patient with myopia desiring to be ...
SNU Eye Clinic explains why early cataract symptoms are often mistaken for presbyopia and why comprehensive eye ...
If you are middle aged and find you have to hold your phone at arm's length to read, you may have presbyopia - a difficulty focusing on close objects that is usually corrected using glasses, contact ...
In recent articles, I have argued for an approach to presbyopia correction that selects a presbyopic IOL according to each patient’s unique presbyopia profile. In my experience, this customized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results